FIS
46
-4
WAT
54
2
FTI
82
4
CL
58
2
PFE
30
-3
SWK
81
-3
BRK.B
42
-3
MDLZ
65
-2
SJM
38
-3
COST
56
3
TXT
58
-2
MCD
67
2
EXPD
53
-3
MAS
67
-3
SLB
53
-3
IVZ
50
-3
IP
39
-6
SYF
65
-6
VNO
57
-2
UNH
53
-3
FIS
46
-4
WAT
54
2
FTI
82
4
CL
58
2
PFE
30
-3
SWK
81
-3
BRK.B
42
-3
MDLZ
65
-2
SJM
38
-3
COST
56
3
TXT
58
-2
MCD
67
2
EXPD
53
-3
MAS
67
-3
SLB
53
-3
IVZ
50
-3
IP
39
-6
SYF
65
-6
VNO
57
-2
UNH
53
-3
Financhill
Back

Direxion Dl Elctrc&Atnms vhcls Bull2XETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
27

EVAV
Direxion Dl Elctrc&Atnms vhcls Bull2XETF

Last Price:
16.78
Seasonality Move:
-46.36%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
27
Direxion Dl Elctrc&Atnms vhcls Bull2XETF (EVAV) is a Sell

Is Direxion Dl Elctrc&Atnms vhcls Bull2XETF a Buy, Sell or Hold?

  • The current Direxion Dl Elctrc&Atnms vhcls Bull2XETF [EVAV] share price is $16.72. The Score for EVAV is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • EVAV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EVAV Stock Price Chart

What is Direxion Dl Elctrc&Atnms vhcls Bull2XETF's stock price today?

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EVAV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 50.88 Buy
Chaikin Money Flow: 1433 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.48 - 17.14) Buy
Bollinger Bands (100): (14.94 - 19.56) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

EVAV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.06 Sell
20-day SMA: 16.56 Buy
50-day SMA: 17.14 Sell
200-day SMA: 22.79 Sell
8-day EMA: 16.93 Sell
20-day EMA: 16.59 Buy
50-day EMA: 16.75 Sell
200-day EMA: 25.79 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Direxion Dl Elctrc&Atnms vhcls Bull2XETF Earnings Growth & EVAV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Direxion Dl Elctrc&Atnms vhcls Bull2XETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):